| Mark Okusa, MD Charlottesville, VA USA Mark D. Okusa, MD, FASN, is a graduate of George Washington University and Medical College of Virginia (MCV). He pursued residency training at the MCV/Virginia Commonwealth University (VCU) and nephrology training at Yale University. He was elected Alpha Omega Alpha, MCV/VCU. He is the John C. Buchanan Distinguished Professor of Medicine, Chief, Division of Nephrology and Director, Center for Immunity, Inflammation and Regenerative Medicine at the University of Virginia, Charlottesville, VA. Through his contributions as PI on an NIH T32, U2C/TL1 and R25 he has promoted the career development of students, postdoctoral trainees and junior faculty. His NIH-funded research focuses on preclinical studies identifying novel targets for AKI and CKD using genetic models of kidney injury. He has published over 200 original manuscripts and book chapters. He has served on advisory committees and study sections for the NIH, ASN, AHA, and NKF and as Chair of the Program Committee of the ASN (2011). Dr. Okusa previously was the Associate Editor of Nephron Physiology, and KI and as well as member of the editorial boards of the AJP: Renal, AJN and JASN. Dr. Okusa has been listed in Castle Connally’s America’s Top Doctors (2001-2021). Dr. Okusa is a member of the American Clinical and Climatological Association, Association of American Physicians and was President of the American Society of Nephrology in 2018. |